TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/24/22 09:43 | 5/20/22 | OCUP | Ocuphire Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Manuso James S J | MI | D | P | 10 | 1.99 | 0 | 5 | 30 | 22 | D | |||||||||||||||
11/22/21 16:01 | 11/18/21 | OCUP | Ocuphire Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Manuso James S J | MI | D | P | 7 | 3.50 | 0 | 2 | 14 | 17 | D | |||||||||||||||
11/25/20 20:13 | 11/19/20 | OCUP | Ocuphire Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Manuso James S J | MI | D | P.d | 0 | 0.00 | 0 | 4 | 44 | 15 | D | |||||||||||||||
12/12/17 18:49 | 9/13/17 | RSPI | Respirerx Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Manuso James S J | NJ | DO | P,CEO | P.d | 0 | 0.00 | 0 | 1 | 1 | 74 | D | ||||||||||||||
8/31/15 16:21 | 8/28/15 | CORX | Cortex Pharmaceuticals Inc/de/ | DE | Health | Drug | Pharmaceutical Preparations | Manuso James S J | NJ | DOT | P,CEO | P.d | 0 | 0.00 | 0 | 11,888 | New | 11,888 | D | ||||||||||||||
3/24/08 19:31 | 3/20/08 | SUPG | Supergen Inc | DE | Health | Drug | Pharmaceutical Preparations | Manuso James S J | CA | DO | P,CEO | P | 5 | 2.29 | 0 | 2 | 136 | 3 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |